Eris Lifesciences Limited (ERIS.NS) NSE
1,383.00
+20.9(+1.53%)
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Eris Lifesciences Limited
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
3620
First IPO Date
June 30, 2017
Key Executives
| Name | Title | Pay | Year Born |
| Inderjeet Singh Negi | Executive Director | 12.4M | 1971 |
| Kaushal Kamlesh Shah | Whole Time Director | 16.82M | 1979 |
| Krishnakumar Vaidyanathan | Executive Director & Chief Operating Officer | 45.78M | 1975 |
| Amit Indubhushan Bakshi | Chairman & MD | 48.78M | 1975 |
| Gagan Atreja | President of Sales & Marketing | 0 | 1969 |
| Milind Talegaonkar | Compliance Officer & Company Secretary | 0 | N/A |
| Vijay S. Joshi | President of Medical | 0 | 1953 |
| Murari Ranganathan | President of Cardiometabolic Business | 0 | N/A |
| Sachin Shah | Chief Financial Officer | 0 | 1980 |
| Deepak Kapoor | Senior Vice President | 0 | 1964 |
Description
Eris Lifesciences Limited manufactures, markets, and distributes pharmaceutical products in India. It offers various branded formulations in various therapeutic areas, such as cardiovascular, antidiabetes, anti-infective, antipyretics, vitamins/nutrients, gastroenterology, respiratory, gynecology, pediatrics, neurology, psychiatry, and pain/analgesics, as well as in-vitro fertilization, cosmetology, and dermatology. Eris Lifesciences Limited was incorporated in 2007 and is based in Ahmedabad, India.
